GPR55 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Moreover, our results suggesting Gpr55 might be a genetic modifier may be specific to our mouse model and future studies are needed to explore whether this translates to Dravet syndrome patients.